Literature DB >> 314367

Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly sequential study of melanoma patients. I. Changes in non-specific (NK, K and T cell) lymphocytotoxicity, peripheral blood counts and delayed hypersensitivity reactions.

N Thatcher, R Swindell, D Crowther.   

Abstract

Increased lymphocyte cytotoxicity, particularly of 'killer' K cell type was recorded with repeated immunizations of either C. parvum or BCG. A 3 week interval between immunizations was capable of maintaining the increase in cytotoxicity. No marked alterations of 'recall' skin hypersensitivity reactions nor of peripheral blood counts were noted. Expression of cytotoxicity results as percentage 51Cr release, lytic units/ml and cytotoxic capacity (after logit transformation of the cytotoxicity-lymphocyte curves) are described. A 3 week immunization schedule is suggested where BCG and C. parvum are used as immunotherapeutic agents, in the doses quoted.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 314367      PMCID: PMC1537734     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  6 in total

1.  Characterization of mononuclear effector cells in human blood.

Authors:  P Hersey; A Edwards; J Edwards
Journal:  Clin Exp Immunol       Date:  1976-01       Impact factor: 4.330

2.  Changes in cellular immunity following nephrectomy for localized and metastatic hypernephroma.

Authors:  N Thatcher; R J Barnard; N Gasiunas; D Crowther
Journal:  Eur J Cancer       Date:  1977-09       Impact factor: 9.162

3.  Effects of Corynebacterium parvum and BCG therapy on immune parameters in patients with disseminated melanoma. A sequential study over 28 days. II. Changes in non-specific (NK, K and T cell) lymphocytoxicity and delayed hypersensitivity skin reactions.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-02       Impact factor: 4.330

4.  Lymphocyte function related to survival curves in patients with metastatic melanoma treated by chemoimmunotherapy.

Authors:  N Thatcher; M K Palmer; R Swindell; D Crowther
Journal:  Med Pediatr Oncol       Date:  1978

5.  Sequential in vitro reactivity of lymphocytes from melanoma patients receiving immunotherapy compared with the reactivity of lymphocytes from healthy donors.

Authors:  J Berkelhammer; M J Mastrangelo; J F Laucius; A J Bodurtha; R T Prehn
Journal:  Int J Cancer       Date:  1975-10-15       Impact factor: 7.396

6.  Lymphocyte function and response to chemo-immunotherapy in patients with metastatic melanoma.

Authors:  N Thatcher; M K Palmer; N Gasiunas; D Crowther
Journal:  Br J Cancer       Date:  1977-12       Impact factor: 7.640

  6 in total
  4 in total

1.  Effects of repeated Corynebacterium parvum and BCG therapy on immune parameters: a weekly study of melanoma patients II. Changes in serum immunoglobulins and lymphoid cell subpopulations.

Authors:  N Thatcher; R Swindell; D Crowther
Journal:  Clin Exp Immunol       Date:  1979-06       Impact factor: 4.330

2.  Membrane glycoprotein M-2 protects against Leishmania amazonensis infection.

Authors:  J Champsi; D McMahon-Pratt
Journal:  Infect Immun       Date:  1988-12       Impact factor: 3.441

3.  Suppression of murine NK activity induced by Corynebacterium parvum: further characterization and abrogation of suppressor cells.

Authors:  V K Milisauskas; G Cudkowicz; I Nakamura
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

Review 4.  Natural killer cells in human solid tumors.

Authors:  M Introna; A Mantovani
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.